M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.383 PLN 1.06% Market Closed
Market Cap: 26m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Gross Margin
Medicofarma Biotech SA

85.6%
Current
41%
Average
43.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
85.6%
=
Gross Profit
1.2m
/
Revenue
1.4m

Gross Margin Across Competitors

Country PL
Market Cap 26m PLN
Gross Margin
86%
Country US
Market Cap 1.3T USD
Gross Margin
55%
Country US
Market Cap 207B USD
Gross Margin
41%
Country US
Market Cap 174.4B USD
Gross Margin
60%
Country KR
Market Cap 67.6T KRW
Gross Margin
50%
Country CH
Market Cap 40.2B CHF
Gross Margin
29%
Country US
Market Cap 38.4B USD
Gross Margin
35%
Country US
Market Cap 38.6B USD
Gross Margin
55%
Country US
Market Cap 26.7B USD
Gross Margin
59%
Country US
Market Cap 24.9B USD
Gross Margin
35%
Country US
Market Cap 23.3B USD
Gross Margin
64%

Profitability Report

View the profitability report to see the full profitability analysis for Medicofarma Biotech SA.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
85.6%
=
Gross Profit
1.2m
/
Revenue
1.4m
What is the Gross Margin of Medicofarma Biotech SA?

Based on Medicofarma Biotech SA's most recent financial statements, the company has Gross Margin of 85.6%.